{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:43:10Z","timestamp":1769103790888,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11239-021-02530-3","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T06:02:30Z","timestamp":1627884150000},"page":"74-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1318-9100","authenticated-orcid":false,"given":"Pablo A.","family":"Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie P.","family":"Belley-C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratika","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare L.","family":"Atzema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander P.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Oldgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the RE-LY AF Registry Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"issue":"1","key":"2530_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cjca.2010.11.014","volume":"27","author":"IG Stiell","year":"2011","unstructured":"Stiell IG, Macle L (2011) Canadian cardiovascular society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department. Can J Cardiol 27(1):38\u201346","journal-title":"Can J Cardiol"},{"issue":"932","key":"2530_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/pmj.79.932.313","volume":"79","author":"A Wakai","year":"2003","unstructured":"Wakai A, O\u2019Neill JO (2003) Emergency management of atrial fibrillation. Postgrad Med J 79(932):313\u2013319","journal-title":"Postgrad Med J"},{"issue":"21","key":"2530_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr et al (2014) AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(21):e1-76","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2530_CR4","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.cjca.2016.07.591","volume":"32","author":"L Macle","year":"2016","unstructured":"Macle L, Cairns J, Leblanc K, Tsang T, Skanes A, Cox JL et al (2016) Focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation. Can J Cardiol 32(10):1170\u20131185","journal-title":"Can J Cardiol"},{"issue":"5","key":"2530_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","volume":"50","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 50(5):e1\u2013e88","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10","key":"2530_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jama.2017.1371","volume":"317","author":"Y Xian","year":"2017","unstructured":"Xian Y, O\u2019Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC et al (2017) Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation. JAMA 317(10):1057\u20131067","journal-title":"JAMA"},{"issue":"13","key":"2530_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.113.002601","volume":"129","author":"JS Dlott","year":"2014","unstructured":"Dlott JS, George RA, Huang X, Odeh M, Kaufman HW, Ansell J et al (2014) National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation. Circulation 129(13):1407\u20131414","journal-title":"Circulation"},{"issue":"16","key":"2530_CR8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/heartjnl-2012-303472","volume":"99","author":"C Cowan","year":"2013","unstructured":"Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M et al (2013) The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart 99(16):1166\u20131172","journal-title":"Heart"},{"issue":"49","key":"2530_CR9","doi-asserted-by":"publisher","first-page":"E1345","DOI":"10.1503\/cmaj.190747","volume":"191","author":"CL Atzema","year":"2019","unstructured":"Atzema CL, Jackevicius CA, Chong A, Dorian P, Ivers NM, Parkash R et al (2019) Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation. CMAJ 191(49):E1345\u2013E1354","journal-title":"CMAJ"},{"issue":"1","key":"2530_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.annemergmed.2004.01.010","volume":"44","author":"P Laguna","year":"2004","unstructured":"Laguna P, Martn A, del Arco C, Gargantilla P (2004) Investigators in the Spanish atrial fibrillation in emergency medicine study G. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study. Ann Emerg Med 44(1):3\u201311","journal-title":"Ann Emerg Med"},{"issue":"6","key":"2530_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.annemergmed.2013.04.004","volume":"62","author":"FX Scheuermeyer","year":"2013","unstructured":"Scheuermeyer FX, Innes G, Pourvali R, Dewitt C, Grafstein E, Heslop C et al (2013) Missed opportunities for appropriate anticoagulation among emergency department patients with uncomplicated atrial fibrillation or flutter. Ann Emerg Med 62(6):557\u201365.e2","journal-title":"Ann Emerg Med"},{"issue":"1","key":"2530_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.annemergmed.2014.07.016","volume":"65","author":"B Coll-Vinent","year":"2015","unstructured":"Coll-Vinent B, Martin A, Malagon F, Suero C, Sanchez J, Varona M et al (2015) Stroke prophylaxis in atrial fibrillation: searching for management improvement opportunities in the emergency department: the HERMES-AF study. Ann Emerg Med 65(1):1\u201312","journal-title":"Ann Emerg Med"},{"issue":"4","key":"2530_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/17482941.2017.1406954","volume":"18","author":"JA Scott-Herridge","year":"2016","unstructured":"Scott-Herridge JA, Seifer CM, Steigerwald R, Drobot G, McIntyre WF (2016) A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department. Acute Card Care 18(4):71\u201378","journal-title":"Acute Card Care"},{"issue":"5","key":"2530_CR14","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1161\/STROKEAHA.116.014855","volume":"48","author":"B Coll-Vinent","year":"2017","unstructured":"Coll-Vinent B, Mart\u00edn A, S\u00e1nchez J, Tamargo J, Suero C, Malag\u00f3n F et al (2017) Benefits of emergency departments\u2019 contribution to stroke prophylaxis in atrial fibrillation: the EMERG-AF study (emergency department stroke prophylaxis and guidelines implementation in atrial fibrillation). Stroke 48(5):1344\u20131352","journal-title":"Stroke"},{"issue":"6","key":"2530_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1017\/cem.2018.415","volume":"20","author":"S Rezazadeh","year":"2018","unstructured":"Rezazadeh S, Chew DS, Miller RJH, Klassen S, Pournazari P, Bennett G et al (2018) Effects of a reminder to initiate oral anticoagulation in patients with atrial fibrillation\/atrial flutter discharged from the emergency department: REMINDER study. CJEM 20(6):841\u2013849","journal-title":"CJEM"},{"issue":"6","key":"2530_CR16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cjca.2018.03.009","volume":"34","author":"RJH Miller","year":"2018","unstructured":"Miller RJH, Chew DS, Rezazadeh S, Klassen S, Pournazari P, Lang E et al (2018) Factors influencing oral anticoagulation prescription for patients presenting to emergency departments with atrial fibrillation and flutter. Can J Cardiol 34(6):804\u2013807","journal-title":"Can J Cardiol"},{"issue":"5","key":"2530_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.annemergmed.2016.10.013","volume":"69","author":"IG Stiell","year":"2017","unstructured":"Stiell IG, Clement CM, Rowe BH, Brison RJ, Wyse DG, Birnie D et al (2017) Outcomes for emergency department patients with recent-onset atrial fibrillation and flutter treated in Canadian hospitals. Ann Emerg Med 69(5):562\u2013571.e2","journal-title":"Ann Emerg Med"},{"key":"2530_CR18","unstructured":"Misra P, Lang E, Clement CM, Brison RJ, Rowe BH, Borgundvaag B et al (2013) Emergency physician patterns related to anticoagulation of patients with recent-onset atrial fibrillation and flutter. J Atr Fibrillation 5(6):645"},{"issue":"2","key":"2530_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5811\/westjem.2017.9.35671","volume":"19","author":"DR Vinson","year":"2018","unstructured":"Vinson DR, Warton EM, Mark DG, Ballard DW, Reed ME, Chettipally UK et al (2018) Thromboprophylaxis for patients with high-risk atrial fibrillation and flutter discharged from the emergency department. West J Emerg Med 19(2):346","journal-title":"West J Emerg Med"},{"issue":"2","key":"2530_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cjca.2017.11.009","volume":"34","author":"CL Atzema","year":"2018","unstructured":"Atzema CL (2018) Stroke prevention for high-risk atrial fibrillation in the emergency setting: the emergency physician perspective. Can J Cardiol 34(2):125\u2013131","journal-title":"Can J Cardiol"},{"issue":"4","key":"2530_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.annemergmed.2015.03.024","volume":"66","author":"CL Atzema","year":"2015","unstructured":"Atzema CL, Austin PC, Chong AS, Dorian P, Jackevicius CA (2015) The long-term use of warfarin among atrial fibrillation patients discharged from an emergency department with a warfarin prescription. Ann Emerg Med 66(4):347-354.e2","journal-title":"Ann Emerg Med"},{"issue":"6","key":"2530_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.annemergmed.2013.05.027","volume":"62","author":"TW Barrett","year":"2013","unstructured":"Barrett TW, Marill KA (2013) Anticoagulation for emergency department patients with atrial fibrillation: is our duty to inform or prescribe? Ann Emerg Med 62(6):566\u2013568","journal-title":"Ann Emerg Med"},{"issue":"10050","key":"2530_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","volume":"388","author":"JS Healey","year":"2016","unstructured":"Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J et al (2016) Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. Lancet (Lond, Engl) 388(10050):1161\u20131169","journal-title":"Lancet (Lond, Engl)"},{"issue":"15","key":"2530_CR24","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","volume":"129","author":"J Oldgren","year":"2014","unstructured":"Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P et al (2014) Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY atrial fibrillation registry. Circulation 129(15):1568\u20131576","journal-title":"Circulation"},{"key":"2530_CR25","unstructured":"Bank W (2011) World Bank list of economies 2011. Available from: https:\/\/openknowledge.worldbank.org\/handle\/10986\/2124. Accessed 1 May 2020"},{"issue":"12","key":"2530_CR26","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1160\/TH17-08-0555","volume":"117","author":"M Mazurek","year":"2017","unstructured":"Mazurek M, Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener H-C et al (2017) Regional differences in antithrombotic treatment for atrial fibrillation: insights from the GLORIA-AF Phase II registry. Thromb Haemost 117(12):2376","journal-title":"Thromb Haemost"},{"issue":"6","key":"2530_CR27","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1378\/chest.11-2888","volume":"142","author":"GYH Lip","year":"2012","unstructured":"Lip GYH, Brechin CM, Lane DA (2012) The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 142(6):1489\u20131498","journal-title":"Chest"},{"issue":"6","key":"2530_CR28","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ihj.2018.09.001","volume":"70","author":"JP Sawhney","year":"2018","unstructured":"Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M et al (2018) Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: insights from the GARFIELD-AF registry. Indian Heart J 70(6):828\u2013835","journal-title":"Indian Heart J"},{"issue":"6","key":"2530_CR29","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamainternmed.2015.0920","volume":"175","author":"JC Hsu","year":"2015","unstructured":"Hsu JC, Chan PS, Tang F, Maddox TM, Marcus GM (2015) Oral anticoagulant prescription in patients with atrial fibrillation and a low risk of thromboembolism: insights from the NCDR PINNACLE registry. JAMA Intern Med 175(6):1062\u20131065","journal-title":"JAMA Intern Med"},{"issue":"10","key":"2530_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the fiamingham study. Neurology 28(10):973","journal-title":"Neurology"},{"issue":"9","key":"2530_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.clineuro.2013.06.017","volume":"115","author":"D Wang","year":"2013","unstructured":"Wang D, Liu M, Lin S, Hao Z, Tao W, Chen X et al (2013) Stroke and rheumatic heart disease: a systematic review of observational studies. Clin Neurol Neurosurg 115(9):1575\u20131582","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"2530_CR32","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.cjca.2019.07.057","volume":"35","author":"A Benz","year":"2019","unstructured":"Benz A, Healey J, Marsden T, Karthikeyan G, Hohnloser S, Oldgren J et al (2019) Stroke risk prediction in patients with atrial fibrillation and rheumatic heart disease: results from the RE-LY AF registry. Can J Cardiol 35(10):S5","journal-title":"Can J Cardiol"},{"issue":"2","key":"2530_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1553-2712.2008.00068.x","volume":"15","author":"GD Kelen","year":"2008","unstructured":"Kelen GD (2008) Public health initiatives in the emergency department: not so good for the public health? Acad Emerg Med Off J Soc Acad Emerg Med 15(2):194","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"issue":"5","key":"2530_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.annemergmed.2012.12.022","volume":"61","author":"CL Atzema","year":"2013","unstructured":"Atzema CL, Austin PC, Chong AS, Dorian P (2013) Factors associated with 90-day death after emergency department discharge for atrial fibrillation. Ann Emerg Med 61(5):539-548.e1","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2530_CR35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1017\/cem.2017.418","volume":"20","author":"D Barbic","year":"2018","unstructured":"Barbic D, DeWitt C, Harris D, Stenstrom R, Grafstein E, Wu C et al (2018) Implementation of an emergency department atrial fibrillation and flutter pathway improves rates of appropriate anticoagulation, reduces length of stay and thirty-day revisit rates for congestive heart failure. Can J Emerg Med 20(3):392\u2013400","journal-title":"Can J Emerg Med"},{"issue":"4","key":"2530_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.annemergmed.2018.09.001","volume":"73","author":"R Parkash","year":"2019","unstructured":"Parkash R, Magee K, McMullen M, Clory M, D\u2019Astous M, Robichaud M et al (2019) The Canadian community utilization of stroke prevention study in atrial fibrillation in the emergency department (C-CUSP ED). Ann Emerg Med 73(4):382\u2013392","journal-title":"Ann Emerg Med"},{"issue":"5","key":"2530_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/europace\/euz302","volume":"22","author":"NM Hawkins","year":"2020","unstructured":"Hawkins NM, Scheuermeyer FX, Youngson E, Sandhu RK, Ezekowitz JA, Kaul P et al (2020) Impact of cardiology follow-up care on treatment and outcomes of patients with new atrial fibrillation discharged from the emergency department. EP Europace 22(5):695\u2013703","journal-title":"EP Europace"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02530-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T14:05:54Z","timestamp":1643205954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02530-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2530"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02530-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"10 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jeff Healey reports research grants and speaking fees from Boehringer-Ingelheim, Bayer, BMS\/Pfizer and Servier.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In the RE-LY AF registry, ethical committees approved the study at participating centers in 47 countries, and sites collected clinical data through interviews with patients, review of medical records and contact with the treating physician.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the RE-LY AF registry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}